Welcome to
Sanofi in Canada
Toggle navigation
About Us
Science & Innovation
Products and Resources
Patient Support
Our Responsibility
Careers
Media
Toggle navigation
News Releases
Subscribe
Media Contacts
Social Media
News
Month Year
Su
Mo
Tu
We
Th
Fr
Sa
25
26
27
28
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
3
4
5
Cancel
Go
Month Year
Su
Mo
Tu
We
Th
Fr
Sa
25
26
27
28
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
3
4
5
Cancel
Go
Subscribe
Year
All Years
2024
2023
2022
2021
2020
2019
2018
2017
Keywords
Go
Advanced Search
Search
Search Headlines Only
From
To
Asset Types
Photos
Video
Audio
Documents
Events
Standard
Apr 10, 2018
Media Advisory - Sanofi to announce significant investment in Canadian vaccine production facility
Mar 10, 2018
Praluent® (alirocumab) significantly reduced risk of cardiovascular events in high-risk patients, and was associated with lower death rate
Feb 23, 2018
Building bridges in the community
Sanofi Canada donates nearly $40,000 to Centraide of Greater Montreal as 2017 Season of Solidarity campaign comes to an end
Dec 12, 2017
The results of a recent study favour Toujeo® over degludec and real-world evidence confirms Toujeo®'s value
Oct 17, 2017
Insulin in People Living with Type 2 Diabetes: Initiation and Dosage
Show
5
10
25
50
100
per page
«
1
…
13
14
15
16
17
18
19
20
21
»